Mellen Center for Multiple Sclerosis | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

343,257 results for “Mellen Center for Multiple Sclerosis”

Trials

View all 294831 →

Effect of Cervical Mobilization on Balance and Plantar Pressure Distribution in Multiple Sclerosis

12 participants · First posted Sep 10, 2020

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

20 participants · First posted Feb 24, 2015

Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis

60 participants · First posted Nov 26, 2019

Drugs

View all 4633 →

Multiple Sclerosis(Progentos)

Multiple Sclerosis (Antolrx)

Multiple sclerosis(Adaptive)

Organizations

View all 2632 →

MULTIPLE SCLEROSIS CENTER OF CALIFORNIA

United States

National Multiple Sclerosis Society

United States

Accelerated Cure Project Inc

United States

News

View all 41161 →

Multiple Sclerosis Research Update: Advances in Understanding and Treatment

Novartis Kesimpta Shows Sustained Efficacy in Multiple Sclerosis Patients Over Seven Years

CALLIPER Trial in Progressive MS Shows Distinct Patient Profile with Lower Inflammatory Activity

Page 1 of 34326